Nothing Special   »   [go: up one dir, main page]

DK1869459T3 - Lipofil farve-baserede assays for clostridial-toksin-aktivitet - Google Patents

Lipofil farve-baserede assays for clostridial-toksin-aktivitet

Info

Publication number
DK1869459T3
DK1869459T3 DK06749210.8T DK06749210T DK1869459T3 DK 1869459 T3 DK1869459 T3 DK 1869459T3 DK 06749210 T DK06749210 T DK 06749210T DK 1869459 T3 DK1869459 T3 DK 1869459T3
Authority
DK
Denmark
Prior art keywords
clostridial toxin
toxin activity
based assays
membrane
activity
Prior art date
Application number
DK06749210.8T
Other languages
English (en)
Inventor
Ester Fernandez-Salas
Lance E Steward
Kei Roger Aoki
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of DK1869459T3 publication Critical patent/DK1869459T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058Neurological cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Glass Compositions (AREA)
  • Valve-Gear Or Valve Arrangements (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK06749210.8T 2005-04-05 2006-04-04 Lipofil farve-baserede assays for clostridial-toksin-aktivitet DK1869459T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66894205P 2005-04-05 2005-04-05
PCT/US2006/012426 WO2006107921A2 (en) 2005-04-05 2006-04-04 Lipophilic dye-based fret assays for clostridial toxin activity

Publications (1)

Publication Number Publication Date
DK1869459T3 true DK1869459T3 (da) 2010-09-27

Family

ID=36975328

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06749210.8T DK1869459T3 (da) 2005-04-05 2006-04-04 Lipofil farve-baserede assays for clostridial-toksin-aktivitet

Country Status (10)

Country Link
US (2) US8124357B2 (da)
EP (2) EP2293064B1 (da)
AT (2) ATE552500T1 (da)
AU (1) AU2006231470B2 (da)
CA (1) CA2604039C (da)
DE (1) DE602006014812D1 (da)
DK (1) DK1869459T3 (da)
ES (1) ES2345506T3 (da)
PT (1) PT1869459E (da)
WO (1) WO2006107921A2 (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7374896B2 (en) * 2001-08-28 2008-05-20 Allergan, Inc. GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity
US7332567B2 (en) * 2001-08-28 2008-02-19 Allergan, Inc. Fret protease assays for clostridial toxins
US8022172B2 (en) * 2001-08-28 2011-09-20 Allergan, Inc. Luminescence resonance energy transfer (LRET) assays for clostridial toxin activity
US7183066B2 (en) * 2002-09-27 2007-02-27 Allergan, Inc. Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxins
US8497081B2 (en) 2004-02-24 2013-07-30 Allergan, Inc. Botulinum toxin screening assays
US7598027B2 (en) * 2004-02-24 2009-10-06 Allergan, Inc. Botulinum toxin screening assays
US8124357B2 (en) * 2005-04-05 2012-02-28 Allergan, Inc. Lipophilic dye-based fret assays for clostridal toxin activity
ATE555387T1 (de) * 2005-10-12 2012-05-15 Allergan Inc Tests der molekularen oder subzellulären nähe unter verwendung von depolarisierung nach resonanzenergietransfer (daret)
EP2118122B1 (en) * 2007-01-16 2015-09-23 The Regents of The University of California Novel antimicrobial peptides
RU2491293C2 (ru) 2008-03-14 2013-08-27 Аллерган, Инк. Иммунологические анализы активности ботулинического токсина серотипа а
KR101604515B1 (ko) * 2008-03-14 2016-03-17 알러간, 인코포레이티드 면역-기반 보툴리눔 독소 세로타입 a 활성 검정
RU2011139364A (ru) 2009-03-13 2013-04-20 Аллерган, Инк. Клетки для применения в иммунологических тестах на активность ботулинического токсина серотипа а
JP5826635B2 (ja) * 2009-03-13 2015-12-02 アラーガン、インコーポレイテッドAllergan,Incorporated 免疫系調節エンドペプチターゼ活性アッセイ
US8129139B2 (en) 2009-07-13 2012-03-06 Allergan, Inc. Process for obtaining botulinum neurotoxin
ES2676277T3 (es) * 2009-10-16 2018-07-18 Biomadison, Inc. Células modificadas genéticamente para el ensayo de transferencia de energía por resonancia con el resto del sustrato de sinaptobrevina
US10246492B2 (en) 2009-10-16 2019-04-02 Biomadison, Inc. Botulinum assay with synaptobrevin substrate moiety
US8940482B1 (en) * 2010-06-11 2015-01-27 Synaptic Research, Llc N-end rule protease activity indication methods and uses thereof
WO2013083847A2 (en) * 2011-12-09 2013-06-13 Institut Pasteur Multiplex immuno screening assay
EP2798077A2 (en) 2011-12-31 2014-11-05 Allergan, Inc. Highly Sensitive Cell-Based Assay to Detect the Presence of Active Botulinum Neurotoxin Serotype-A
US8778623B2 (en) * 2012-09-14 2014-07-15 Wisconsin Alumni Research Foundation Compositions and methods of using differentiated cells sensitized to botulinum neurotoxin
US8962340B2 (en) 2012-12-03 2015-02-24 Src, Inc. Real-time assay for the detection of botulinum toxin
DE102013226511B4 (de) 2013-12-18 2016-12-15 TRUMPF Hüttinger GmbH + Co. KG Leistungsversorgungssystem und Verfahren zur Erzeugung einer Leistung
DE102013226537B4 (de) 2013-12-18 2022-12-29 TRUMPF Hüttinger GmbH + Co. KG Leistungsversorgungssystem mit mehreren Verstärkerpfaden sowie Verfahren zur Anregung eines Plasmas
CN107001451A (zh) 2014-07-07 2017-08-01 阿勒根公司 检测组织样品中裂解的snap25的方法
US9788776B1 (en) 2014-09-22 2017-10-17 Verily Life Sciences Llc Protein M-based in vivo diagnostic system and detection method
US9927442B1 (en) 2014-10-31 2018-03-27 Verily Life Sciences Llc Biosensor for in vitro detection system and method of use
KR102514666B1 (ko) * 2014-12-19 2023-03-27 메르츠 파마 게엠베하 운트 코. 카가아 세포에서 BoNT/E의 생물학적 활성의 결정을 위한 수단 및 방법
DK3432916T3 (da) 2016-09-13 2019-11-11 Allergan Inc Stabiliseret ikke-protein clostridtoxinsammensætninger
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
AU2018389104A1 (en) 2017-12-20 2020-07-30 Allergan, Inc. Botulinum toxin cell binding domain polypeptides and methods of use for skin rejuvenation
AR119109A1 (es) * 2019-06-07 2021-11-24 Synaptic Res Llc Células genéticamente manipuladas
WO2021028868A1 (en) * 2019-08-13 2021-02-18 Synaptic Research, Llc Cells highly sensitive to clostridial neurotoxin
CN110840914B (zh) * 2019-11-23 2021-07-06 博雅干细胞科技有限公司 细胞治疗剂用于缓解或改善血管病变的方法
CN110882276B (zh) * 2019-11-23 2021-07-06 博雅干细胞科技有限公司 细胞治疗组合物及治疗血管病变的方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965699A (en) 1996-11-06 1999-10-12 The United States Of America As Represented By The Secretary Of The Army Assay for the proteolytic activity of serotype a from clostridium botulinum
US7090976B2 (en) 1999-11-10 2006-08-15 Rigel Pharmaceuticals, Inc. Methods and compositions comprising Renilla GFP
FR2809733B1 (fr) 2000-06-02 2004-04-30 Inst Nat Sante Rech Med Substrat peptidique reconnu par la toxine botulique de type bont/b et son utilisation pour doser et/ou detecter ladite toxine ou des inhibiteurs correspondants
WO2002025284A2 (en) 2000-09-25 2002-03-28 U.S. Medical Research Institute Of Infectious Diseases High-throughput assays for the proteolytic activities of clostridial neurotoxins
US7332567B2 (en) 2001-08-28 2008-02-19 Allergan, Inc. Fret protease assays for clostridial toxins
US7208285B2 (en) 2001-08-28 2007-04-24 Allergan, Inc. Fret protease assays for botulinum serotype A/E toxins
US20060063221A1 (en) 2004-09-21 2006-03-23 Williams Dudley J Lanthanide-based substrates and methods for determining clostridial toxin activity
US7374896B2 (en) 2001-08-28 2008-05-20 Allergan, Inc. GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity
WO2004020748A1 (en) 2002-08-28 2004-03-11 Btb Wallercode Sdn Bhd Rainwater collection, storage and supply system
AU2003279020A1 (en) 2002-09-26 2004-04-19 Rensselaer Polytechnic Institute Analytical instruments for monitoring photopolymerization
US7183066B2 (en) 2002-09-27 2007-02-27 Allergan, Inc. Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxins
WO2004031355A2 (en) 2002-10-01 2004-04-15 University Of Maryland Methods for identifying inhibitors of botulinum neurotoxins
US20050100983A1 (en) * 2003-11-06 2005-05-12 Coley Pharmaceutical Gmbh Cell-free methods for identifying compounds that affect toll-like receptor 9 (TLR9) signaling
EP2332959B1 (en) 2003-12-19 2014-11-26 Wisconsin Alumni Research Foundation Method and compositions for detecting botulinum neurotoxin
ES2297742T3 (es) 2004-05-05 2008-05-01 Pharmaleads Sustratos peptidicos reconocidos por la toxina botulinica de tipo a, bont/a y sus usos.
US7399607B2 (en) 2004-09-22 2008-07-15 Allergan, Inc. Fluorescence polarization assays for determining clostridial toxin activity
US8124357B2 (en) * 2005-04-05 2012-02-28 Allergan, Inc. Lipophilic dye-based fret assays for clostridal toxin activity

Also Published As

Publication number Publication date
ES2345506T3 (es) 2010-09-24
US20080160561A1 (en) 2008-07-03
US8124357B2 (en) 2012-02-28
AU2006231470A1 (en) 2006-10-12
ATE552500T1 (de) 2012-04-15
PT1869459E (pt) 2010-08-10
US20120231538A1 (en) 2012-09-13
EP1869459B1 (en) 2010-06-09
US8535941B2 (en) 2013-09-17
EP1869459A2 (en) 2007-12-26
AU2006231470B2 (en) 2011-12-01
DE602006014812D1 (de) 2010-07-22
EP2293064A1 (en) 2011-03-09
WO2006107921A2 (en) 2006-10-12
CA2604039A1 (en) 2006-10-12
EP2293064B1 (en) 2012-04-04
CA2604039C (en) 2014-09-16
WO2006107921A3 (en) 2007-01-18
ATE470857T1 (de) 2010-06-15

Similar Documents

Publication Publication Date Title
DK1869459T3 (da) Lipofil farve-baserede assays for clostridial-toksin-aktivitet
NO20051049D0 (no) Celle-baserte fluorescens-resonans energi overforings (FRET)-analyser for Clostridietoksiner
WO2004041061A3 (en) Substrates, devices, and methods for cellular assays
WO2008036060A3 (en) Clostridial toxin activity assays
ATE528648T1 (de) Verfahren zum nachweis antikörper-herstellender zellen
ATE527383T1 (de) Multiplex-nukleinsäurenachweis
WO2005005977A3 (en) Fluorescent phospholipase assays and compositions
ATE330038T1 (de) Nukleinsäure-biosensor
AU2001237981A1 (en) Immunochromatographic methods for detecting an analyte in a sample which employ semiconductor nanocrystals as detectable labels
WO2005047863A3 (en) Substrates, devices, and methods for cellular assays
WO2009058902A3 (en) Methods and devices for analyte detection
DK1329724T3 (da) Assayindretning og -fremgangsmåde til lipoprotein med höj densitet
ATE532830T1 (de) Langwellige thiolgruppenreaktive fluorophore
ATE466098T1 (de) Kinase- und phosphatasetests
DK1946083T3 (da) Fremgangsmåde til detektion af biologiske organismer under anvendelse af ramanspredning
ATE467128T1 (de) Kolloidale metallkonjugate
DE60113811D1 (de) NACHWEIS DER BINDUNG VON Ladungsträgern mittels PH- ODER POTENTiaL-SENSITIVEr SONDEN
FR2853077B1 (fr) Procedes immunochromatographiques en phase solide
DK1771732T3 (da) Taxol-immunassay
WO2007133496A3 (en) Development of a novel assay for mgmt (methyl guanine transferase)
ATE371747T1 (de) Dendritische chemilumineszierende substrate
WO2008021071A3 (en) Substrates, devices, and methods for cellular assays
DE60332479D1 (de) Holo-transcobalamin bindungspartner und ihre verwendung in cobalamintest
DE602004016906D1 (de) Reagenz zum Nachweis von anti-Phospholipid Antikörper
NO20044145L (no) Assay for anti-INGAP antistoffer